Cytotoxic T-Lymphocyte escape mutations identified by HLA association favor those which escape and revert rapidly

Journal of Virology

Volumn 86, Issue 16, 2012, Pages 8568-8580

  Fryer, Helen R ^a,b   Frater, John ^a,c   Duda, Anna ^c   Palmer, Duncan ^b   McLean, Rodney E Phillips ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA ANTIGEN; HLA ANTIGEN CLASS 1;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EPIDEMIC; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; HLA MATCHING; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE EVASION; MAJOR CLINICAL STUDY; MALE; MOLECULAR EVOLUTION; MOLECULAR PHYLOGENY; MUTATION RATE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; REVERTANT; VIRUS CELL INTERACTION; VIRUS LOAD; VIRUS TRANSMISSION;

EPITOPES, T-LYMPHOCYTE; GENES, MHC CLASS I; HIV; HIV INFECTIONS; HUMANS; MODELS, THEORETICAL; MUTATION; PHYLOGENY; T-LYMPHOCYTES, CYTOTOXIC; VIRAL PROTEINS;

EID: 84865063695     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.07020-11     Document Type: Article

References (42)

1. Anderson RM, May RM. 1991. Infectious diseases of humans: dynamics and control. Oxford University Press, Oxford, United Kingdom.
2. Berger CT, et al. 2010. Viral adaptation to immune selection pressure by HLA class I-restricted CTL responses targeting epitopes in HIV frameshift sequences. J. Exp. Med. 207:61-75.
3. Bhattacharya T, et al. 2007. Founder effects in the assessment of HIV polymorphisms and HLA allele associations. Science 315:1583-1586.
4. Borrow P, et al. 1997. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat. Med. 3:205-211.
5. Borrow P, Lewicki H, Hahn BH, Shaw GM, Oldstone MB. 1994. Virus-specific CD8_ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68:6103-6110.
6. Boutwell CL, Essex M. 2007. Identification of HLA class I-associated amino acid polymorphisms in the HIV-1C proteome. AIDS Res. Hum. Retroviruses 23:165-174.
7. Brumme ZL, et al. 2007. Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1. PLoS Pathog. 3:e94. doi:10.1371/journal.ppat.0030094.
8. Brumme ZL, et al. 2009. HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins. PLoS One 4:e6687. doi: 10.1371/journal.pone.0006687.
9. Brumme ZL, et al. 2008. Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection. J. Virol. 82:9216-9227.
10. Carlson J, Kadie C, Mallal S, Heckerman D. 2007. Leveraging hierarchical population structure in discrete association studies. PLoS One 2:e591. doi:10.1371/journal.pone.0000591.
11. Carlson JM, Brumme ZL. 2008. HIV evolution in response to HLArestricted CTL selection pressures: a population-based perspective. Microbes Infect. 10:455-461.
12. Carlson JM, et al. 2008. Phylogenetic dependency networks: inferring patterns of CTL escape and codon covariation in HIV-1 Gag. PLoS Comput. Biol. 4:e1000225. doi:10.1371/journal.pcbi.1000225.
13. Carrington M, O'Brien SJ. 2003. The influence of HLA genotype on AIDS. Annu. Rev. Med. 54:535-551.
14. Duda A, et al. 2009. HLA-associated clinical progression correlates with epitope reversion rates in early human immunodeficiency virus infection. J. Virol. 83:1228-1239.
15. Felsenstein J, Churchill GA. 1996. A hidden Markov Model approach to variation among sites in rate of evolution. Mol. Biol. Evol. 13:93-104.
16. Frater AJ, et al. 2007. Effective T-cell responses select human immunodeficiency virus mutants and slow disease progression. J. Virol. 81:6742-6751.
17. Fryer HR, et al. 2010. Modelling the evolution and spread of HIV immune escape mutants. PLoS Pathog. 6:e1001196. doi:10.1371/ journal.ppat.1001196.
18. Furutsuki T, et al. 2004. Frequent transmission of cytotoxic-Tlymphocyte escape mutants of human immunodeficiency virus type 1 in the highly HLA-A24-positive Japanese population. J. Virol. 78:8437-8445.
19. Geels MJ, et al. 2006. CTL escape and increased viremia irrespective of HIV-specific CD4_ T-helper responses in two HIV-infected individuals. Virology 345:209-219.
20. Gesprasert G, et al. 2010. HLA-associated immune pressure on Gag protein in CRF01_AE-infected individuals and its association with plasma viral load. PLoS One 5:e11179. doi:10.1371/journal.pone.0011179.
21. Goonetilleke N, et al. 2009. The first T cell response to transmitted/ founder virus contributes to the control of acute viremia in HIV-1 infection. J. Exp. Med. 206:1253-1272.
22. Huang KH, et al. 2011. Progression to AIDS in South Africa is associated with both reverting and compensatory viral mutations. PLoS One 6:e19018. doi:10.1371/journal.pone.0019018.
23. Kawashima Y, et al. 2009. Adaptation of HIV-1 to human leukocyte antigen class I. Nature 458:641-645.
24. Kelleher AD, et al. 2001. Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J. Exp. Med. 193:375-386.
25. Kiepiela P, et al. 2004. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 432:769-775.
26. Korber B, et al. 2000. Timing the ancestor of the HIV-1 pandemic strains. Science 288:1789-1796.
27. Koup RA, et al. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650-4655.
28. Leslie AJ, et al. 2004. HIV evolution: CTL escape mutation and reversion after transmission. Nat. Med. 10:282-289.
29. Li B, et al. 2007. Rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolution. J. Virol. 81:193-201.
30. Marsh SGE, Parham P, Barber LD. 2000. The HLA factsbook. Academic Press, London, United Kingdom.
31. Matthews PC, et al. 2008. Central role of reverting mutations in HLA associations with human immunodeficiency virus set point. J. Virol. 82: 8548-8559.
32. Miura T, et al. 2009. HLA-associated viral mutations are common in human immunodeficiency virus type 1 elite controllers. J. Virol. 83:3407-3412.
33. Moore CB, et al. 2002. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 296:1439-1443.
34. Morgan D, et al. 2002. HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries? AIDS 16:597-603.
35. Oxenius A, et al. 2002. Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection. Proc. Natl. Acad. Sci. U. S. A. 99:13747-13752.
36. Phillips RE, et al. 1991. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354:453-459.
37. Pillay T, et al. 2005. Unique acquisition of cytotoxic T-lymphocyte escape mutants in infant human immunodeficiency virus type 1 infection. J. Virol. 79:12100-12105.
38. Pond SL, et al. 2006. Adaptation to different human populations by HIV-1 revealed by codon-based analyses. PLoS Comput. Biol. 2:e62. doi: 10.1371/journal.pcbi.0020062.
39. Price DA, et al. 1997. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc. Natl. Acad. Sci. U. S. A. 94:1890-1895.
40. Rousseau CM, et al. 2008. HLA class I-driven evolution of human immunodeficiency virus type 1 subtype c proteome: immune escape and viral load. J. Virol. 82:6434-6446.
41. Scherer A, et al. 2004. Quantifiable cytotoxic T lymphocyte responses and HLA-related risk of progression to AIDS. Proc. Natl. Acad. Sci. U. S. A. 101:12266-12270.
42. Tavaré S. 1986. Some probabilistic and statistical problems in the analysis of DNA sequences. American Mathematical Society. Lectures on Mathematics in the Life Sciences. 17:57-86.